These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32548712)
21. A multicenter paper-based and web-based system for collecting patient-reported outcome measures in patients undergoing local treatment for prostate cancer: first experiences. Kowalski C; Roth R; Carl G; Feick G; Oesterle A; Hinkel A; Steiner T; Brock M; Kaftan B; Borowitz R; Zantl N; Heidenreich A; Neisius A; Darr C; Bolenz C; Beyer B; Pfitzenmaier J; Brehmer B; Fichtner J; Haben B; Wesselmann S; Dieng S J Patient Rep Outcomes; 2020 Jul; 4(1):56. PubMed ID: 32661594 [TBL] [Abstract][Full Text] [Related]
22. [Quality of Care in Certified Lung Cancer Centers]. Kowalski C; Ferencz J; Ukena D; Hoffmann H; Wesselmann S Pneumologie; 2015 Jun; 69(6):329-34. PubMed ID: 25822008 [TBL] [Abstract][Full Text] [Related]
23. [Does structural and process quality of certified prostate cancer centers result in better medical care?]. Kranz J; Grundmann RT; Steffens JA Urologe A; 2021 Jan; 60(1):59-66. PubMed ID: 32876699 [TBL] [Abstract][Full Text] [Related]
24. How to implement the requirements of a quality assurance system for prostate cancer. Noris Chiorda B; Zollo F; Magnani T; Badenchini F; Gatto L; Claps M; Macchi A; Andreoli L; Nicolai N; Villa S; Valdagni R World J Urol; 2021 Jan; 39(1):41-47. PubMed ID: 31776738 [TBL] [Abstract][Full Text] [Related]
25. Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis. Bierbaum V; Schmitt J; Klinkhammer-Schalke M; Schoffer O Gesundheitswesen; 2023 Sep; 85(S 03):S197-S204. PubMed ID: 37751756 [TBL] [Abstract][Full Text] [Related]
26. [Specialised treatment of colorectal cancer in certified cancer centres: Do patients really have to travel further?]. Berger E; Reichebner C; Eriksen A; Hildebrandt M; Kuklinski D; Busse R Gesundheitswesen; 2023 Jul; 85(7):657-666. PubMed ID: 37321253 [TBL] [Abstract][Full Text] [Related]
27. Establishment of the Certification System "Gynaecological Dysplasia" in Germany. Beckmann MW; Quaas J; Bischofberger A; Kämmerle A; Lux MP; Wesselmann S Geburtshilfe Frauenheilkd; 2014 Sep; 74(9):860-867. PubMed ID: 25278628 [TBL] [Abstract][Full Text] [Related]
28. [Quality-assured treatment in certified breast cancer centre networks in Upper Franconia, Germany: An analysis based on data of the Bavarian Cancer Registry]. Friebel S; Thater A; Völkel V; Klinkhammer-Schalke M; Müller-Nordhorn J; Emmert M Gesundheitswesen; 2024 Jul; 86(7):515-522. PubMed ID: 38565190 [TBL] [Abstract][Full Text] [Related]
29. Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients. Kreienberg R; Wöckel A; Wischnewsky M Breast; 2018 Aug; 40():54-59. PubMed ID: 29698925 [TBL] [Abstract][Full Text] [Related]
30. Predictors of the regional variation of prostatectomy or radiotherapy: evidence from German cancer registries. Medenwald D; Ferencz J; Vordermark D J Cancer Res Clin Oncol; 2020 May; 146(5):1197-1204. PubMed ID: 32130481 [TBL] [Abstract][Full Text] [Related]
31. [DKG Certification of Paediatric Cancer Centres]. Mensah J; Jürgens H; Eggert A; Wesselmann S Klin Padiatr; 2018 Oct; 230(6):314-318. PubMed ID: 30180265 [TBL] [Abstract][Full Text] [Related]
32. Implementing quality metrics in European Cancer Centers (ECCs). Griesshammer E; Adam H; Sibert NT; Wesselmann S World J Urol; 2021 Jan; 39(1):49-56. PubMed ID: 32253584 [TBL] [Abstract][Full Text] [Related]
33. Brachytherapy boost for prostate cancer: A national survey from Groupe curiethérapie - Société française de radiothérapie oncologique. Lam Cham Kee D; Peiffert D; Hannoun-Lévi JM Cancer Radiother; 2019 Dec; 23(8):847-852. PubMed ID: 31375324 [TBL] [Abstract][Full Text] [Related]
34. [Certification of head and neck tumor centers by the German Cancer Society : an overview]. Winter A; Iro H; Wolff KD; Wesselmann S HNO; 2013 Nov; 61(11):914-20. PubMed ID: 24221220 [TBL] [Abstract][Full Text] [Related]
35. Variations in quality of care for men with early-stage prostate cancer. Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460 [TBL] [Abstract][Full Text] [Related]
36. Treatment choice and quality of care for men with localized prostate cancer. Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826 [TBL] [Abstract][Full Text] [Related]
37. [Opening of the Geneva University Hospital Prostate Cancer Center]. Wirth GJ; Zilli T; Roth A; Amram ML; Biton C; Tille JC; Pusztaszeri M; Rubbia-Brandt L; Vallée JP; De Perrot T; Willi JP; Ratib O; Battagin-Fritsch A; Dietrich PY; Miralbell R; Iselin C Rev Med Suisse; 2014 Dec; 10(453):2302-5. PubMed ID: 25626245 [TBL] [Abstract][Full Text] [Related]
38. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run. Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141 [TBL] [Abstract][Full Text] [Related]
39. [Treatment in Certified Centres (DKG): Decision Factors of Lung Cancer Patients]. Schirrmacher R; Rieger B; Justenhoven C Pneumologie; 2022 Aug; 76(8):547-551. PubMed ID: 35868330 [TBL] [Abstract][Full Text] [Related]
40. [Accessibility of organ cancer centres: is there already nation-wide coverage in Germany?]. Lewers D; Geraedts M Gesundheitswesen; 2015 Jan; 77(1):24-30. PubMed ID: 24566838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]